ImmunologybioRxivPreprint
Immunoreactivity against SLC3A2 in high grade gliomas displays positive correlation with glioblastoma patient survival: Potential target for glioma diagnosis and therapy
N. Karakas, O. Topcu, E. Tuzun…·H. Korkaya
The paper identifies SLC3A2 as an autoantigen in high-grade gliomas, showing its immunoreactivity correlates with improved patient survival.
DOI 10.1101/2023.01.26.525653